November 9-11, 2020 | Virtual Conference


Ronny Gal, PhD

Sanford Bernstein

Aaron (Ronny) Gal is the Senior Analyst at Bernstein covering Global Specialty Pharmaceuticals. Prior to joining Bernstein in 2004, Ronny spearheaded Canon’s business development in life sciences. He also spent six years with the Boston Consulting Group, advising clients in the pharmaceuticals and healthcare delivery industries. Ronny was awarded a PhD from the Massachusetts Institute of Technology and holds a BSc from Emory University. Ronny has been a top analyst in Institutional Investor’s All-America Research Team survey for the past seven years; ranking either No. 1 or No.2 in his sector.

Skip to content